ClinicalTrials.gg
RecruitingNCT07330349DIRECTUpdated Jan 9, 2026

Alcohol, Psychoactive Drugs, Analgesics and Evaluation in Penetrating Abdominal Trauma

An observational study in Abdominal Injuries, Alcohol Intoxication and Substance-related Disorders, sponsored by Fundacion Clinica Valle del Lili. Recruiting at 2 sites in Colombia. Open to participants aged 15 Years and older. Per ClinicalTrials.gov, last updated 2026-01-09.

Sponsored by Fundacion Clinica Valle del Lili · Observational

From the registry’s dates

  • Started Nov 2020; still recruiting 5 years 11 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
363
Ages
15 Years and older
Sex
All
01

Study summary

This prospective observational study aims to evaluate whether alcohol consumption, psychoactive drug use, or prior administration of analgesics affects the clinical evaluation and surgical decision-making process in patients with penetrating abdominal trauma.

The study will be conducted in two level I trauma centers in Cali, Colombia: a public university hospital and a private university hospital, both with high volumes of trauma patients and established protocols for non-operative management using serial physical examination.

In many trauma centers, serial physical examination is used to safely identify patients who require surgical intervention. However, there is concern that intoxication or altered mental status may reduce the reliability of physical examination, potentially leading to unnecessary imaging studies, delays in surgical decision-making, or non-therapeutic laparotomies. Despite this concern, available evidence supporting these assumptions is limited.

Patients older than 14 years with penetrating abdominal trauma who undergo clinical evaluation to decide on surgical intervention. Patients will be classified according to the presence or absence of alcohol consumption, psychoactive substance use, or prior analgesic administration. The primary outcome is the time from hospital admission to the decision for surgical intervention. Secondary outcomes include trauma severity, need for surgery, length of hospital and intensive care unit stay, complications, and mortality.

By comparing patients with and without substance exposure across two different trauma care settings, this study seeks to determine whether serial physical examination remains a reliable and safe method for clinical decision-making in this population. The results may help optimize evaluation strategies, reduce unnecessary surgical procedures and diagnostic tests, and improve the standardization of care for patients with penetrating abdominal trauma.

Read the detailed description

This is a prospective observational cohort study designed to evaluate the impact of alcohol consumption, psychoactive drug use, and prior administration of analgesics on the clinical evaluation process and surgical decision-making in patients with penetrating abdominal trauma.

The study will be conducted at two level I trauma centers in Cali, Colombia: one public university hospital and one private university hospital. Both institutions manage a high volume of trauma patients and apply standardized protocols based on serial physical examination for the evaluation of patients with penetrating abdominal trauma.

Patients older than 14 years who present with penetrating abdominal trauma and are hemodynamically stable will be evaluated according to routine institutional protocols, including serial abdominal physical examinations and selective use of diagnostic adjuncts such as focused abdominal sonography for trauma (FAST) or computed tomography, when clinically indicated. No additional diagnostic or therapeutic interventions will be performed as part of the study.

The exposure of interest is the presence of alcohol consumption, psychoactive substance use, or prior administration of analgesics before or during the initial clinical evaluation. These exposures will be identified through clinical assessment and medical record review and will be categorized according to predefined operational definitions.

The primary analytical focus is the interval between hospital admission and the decision for surgical intervention. Secondary analyses will explore associations between substance exposure and trauma severity, need for operative management, length of hospital stay, intensive care unit admission and length of stay, postoperative complications, and in-hospital mortality.

Data will be collected prospectively using standardized electronic case report forms. Data quality will be ensured through predefined range checks, consistency rules, and periodic review of entered data by the study investigators. Source data verification will be performed by comparing selected registry variables with information documented in the medical records.

Sample size was estimated to detect a clinically relevant difference in time to surgical decision between exposed and non-exposed patients, assuming an alpha level of 0.05, a statistical power of 80%, and an expected hazard ratio of 0.7. Based on the anticipated probability of requiring laparotomy of 0.68, a total of 247 events (laparotomies) were required, corresponding to 363 patients, to ensure an adequate number of events for time-to-event analysis.

Statistical analysis will include descriptive summaries of baseline characteristics, comparison of categorical variables using chi-square or Fisher's exact tests, and comparison of continuous variables using parametric or non-parametric methods as appropriate. Time-to-event analyses will be performed using Cox proportional hazards regression models, adjusting for relevant covariates such as age, sex, mechanism of injury, trauma severity, and type of substance exposure.

This study is observational and involves minimal risk to participants, as all evaluations and management decisions are part of standard clinical care. The results are expected to provide evidence regarding the reliability of serial physical examination in patients with penetrating abdominal trauma who present under the influence of alcohol, psychoactive substances, or analgesics, and may contribute to improving and standardizing trauma evaluation protocols across different clinical settings.

02

Conditions studied

  • Abdominal Injuries
  • Alcohol Intoxication
  • Substance-related Disorders
  • Penetrating Abdominal Trauma

Keywords

  • Trauma decision making
  • Time to surgery
  • Penetrating abdominal trauma
  • Alcohol use
  • Psychoactive substances
  • Analgesic administration
03

In context

Abdominal Injuries

60 studies on the registry are indexed under Abdominal Injuries; 19 are open to participants now.

This study's planned enrollment of 363 is above the median of 200 across 30 observational studies indexed under Abdominal Injuries.

Browse Abdominal Injuries studies →

Lead sponsor

Fundacion Clinica Valle del Lili is the lead sponsor of 25 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population includes patients aged 14 years and older presenting with penetrating abdominal trauma to two university-affiliated trauma centers in Cali, Colombia (one public and one private). Patients are evaluated and managed according to standard trauma care protocols, including immediate operative management or clinical observation with serial physical examination, as clinically indicated. The study assesses the impact of alcohol consumption, psychoactive substance use, and analgesic administration on the clinical evaluation process and surgical decision-making during hospitalization.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients presenting to the emergency department with penetrating abdominal trauma.
  • Age 14 years or older.
  • Patients evaluated and managed according to standard trauma care protocols, including immediate operative management or clinical observation with serial physical examination, as clinically indicated.
  • Patients admitted to the participating trauma centers during the study period.

Exclusion criteria

Exclusion Criteria:

  • Patients transferred from another institution after initial surgical intervention.
  • Patients declared dead on arrival.
  • Patients with incomplete or missing clinical data precluding assessment of outcomes of interest.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
363 participants (estimated)
Target follow-up
28 Days
Patient registry
Yes

Groups and cohorts

  • Patients with Penetrating Abdominal Trauma

    Patients presenting with penetrating abdominal trauma who are evaluated and managed according to standard trauma care protocols, including immediate operative management or clinical observation with serial physical examination, as clinically indicated.

    Other: Alcohol consumption · Other: Psychoactive substance use · Other: Analgesic administration

Interventions

  • OtherAlcohol consumption

    Alcohol consumption prior to hospital admission, identified through patient report, clinical assessment, or laboratory testing when available, and observed as part of routine trauma care, not assigned by the study.

  • OtherPsychoactive substance use

    Use of psychoactive substances prior to hospital admission, identified through clinical history, physical examination, or toxicology screening when available, and observed without modification by the study protocol.

  • OtherAnalgesic administration

    Administration of analgesic medications prior to or during initial hospital evaluation as part of standard trauma care, not assigned, standardized, or modified by the study.

06

What researchers measure

Primary outcomes

  1. Time to surgical decision

    Time elapsed from hospital admission to the clinical decision to proceed with surgical intervention, measured in hours, based on standard trauma care assessment.

    Time frame: Up to 28 days

Secondary outcomes

  1. Need for surgical intervention

    Requirement of operative management during hospital stay.

    Time frame: Up to 28 days

  2. Time to surgery

    Time elapsed from hospital admission to the start of surgical intervention, measured in hours.

    Time frame: Up to 28 days

  3. In-hospital mortality

    Death occurring during the index hospitalization.

    Time frame: During hospitalization (Up to 28 days)

  4. Trauma severity

    Trauma severity will be assessed using ATI (Abdominal trauma index).

    Time frame: 28 Days

  5. Intraoperative bleeding

    Intraoperative bleeding will be assessed by estimating total blood loss during the surgical procedure described by surgeon.

    Time frame: 28 days

07

Study locations

2 of 2 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes

Supporting information: Study protocol, Statistical analysis plan

Time frame: Upon completion of the analysis and for up to five years thereafter

Access criteria: Data will be shared on an individual basis with all individuals who make a reasonable request aimed at contributing to scientific knowledge

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07330349
Lead sponsor
Fundacion Clinica Valle del Lili
Collaborators
Hospital Universitario del Valle Evaristo Garcia
Responsible party
Alberto Federico García (Trauma and Acute Care Surgeon, Fundacion Clinica Valle del Lili) — Principal investigator
First posted
Jan 9, 2026
Start date
Nov 25, 2020
Primary completion
Dec 24, 2025
Completion
Jan 30, 2026 (estimated)
Last update
Jan 9, 2026

Study contacts

Sergio I Prada Ríos, PhD
Contact
sergio.prada@fvl.org.co
+57 6023319090 ext. 4380
Alberto F García, MD, MSc
Contact
alberto.garcia@fvl.org.co
+57 3154676870

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion